MedTrace Logo

Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

NCT01591070 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2012-08-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether proactive use of 0.1% tacrolimus ointment once or twice weekly can keep adult facial SD in remission and reduce the incidence of exacerbation.

Conditions

  • Seborrheic Dermatitis

Interventions

DRUG

Tacrolimus

0.1% tacrolimus once-weekly application for 10 weeks

DRUG

Tacrolimus

0.1% tacrolimus twice weekly application for 10 weeks

Sponsors & Collaborators

  • Pusan National University Hospital

    lead OTHER

Principal Investigators

  • Byung-Soo Kim, Ph.D. · Pusan National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01591070 on ClinicalTrials.gov